WeissLaw LLP Investigates Velcera, Inc. Acquisition

NEW YORK--(BUSINESS WIRE)--WeissLaw LLP, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Velcera, Inc. (“Velcera” or the “Company”) (OTC: VLCR) arising from its agreement for Velcera to be acquired by Perrigo Company (“Perrigo”) in a transaction valued at approximately $160 million. Under the terms of the proposed transaction Velcera shareholders will receive $0.40 in cash for each Velcera share they own.

WeissLaw LLP is investigating whether Velcera’s Board acted in the best interests of its public shareholders by actively shopping the Company to maximize shareholder value for Velcera’s public shareholders, prior to entering into the proposed transaction with Perrigo. Notably, the offer price of $0.40 per share is a significant discount to Velcera’s 52-week high of $1.50 per share and yesterday’s close of $0.60 per share. If you own Velcera shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Kelly C. Keenan either by telephone at [phone] or by email at [e-mail].

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or issuing materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [e-mail] or fill out the form on our website, http://www.weisslawllp.com/contact/report_fraud/.

Attorney Advertising. Past results do not guarantee a similar outcome.